Heterogeneity of cerebral capillary flow in man and its consequences for estimation of blood-brain barrier permeability
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Heterogeneity of cerebral capillary flow in man and its consequences for estimation of blood-brain barrier permeability. / Hertz, M M; Paulson, O B.
In: The Journal of Clinical Investigation, Vol. 65, No. 5, 05.1980, p. 1145-51.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Heterogeneity of cerebral capillary flow in man and its consequences for estimation of blood-brain barrier permeability
AU - Hertz, M M
AU - Paulson, O B
PY - 1980/5
Y1 - 1980/5
N2 - Blood-brain barrier permeability studies made in man using the indicator dilution method revealed that the extraction of the test substance increases during the upslope of the venous (outflow) dilution curve. The present study aimed to obviate the possibility that this could result from intravascular phenomena, such as interlaminar diffusion (the result of differences in molecular size) and erythrocyte carriage. Several reference substances were employed for the determination of the extraction in order that careful correction could be made for differences in intravascular behavior of the test and reference substance. The test substances studied were D-glucose, L-phenylalanine, water, propranolol, and benzodiazepines, representing both carrier-transported and lipophilic substances. In-diethylenetriamine pentaacetic acid, Na+, Cl-, L-glucose, and L-lysine were employed as reference substances. For all the substances tested, and after correction for intravascular phenomena, the extractions were found to increase during the initial part of the dilution curve. This increasing extraction can be ascribed to heterogeneity of the cerebral circulation; the higher extraction corresponds to longer contact with the blood-brain barrier and indicates a longer transit time. Signs of heterogeneity were also present when blood flow was elevated above normal. Any influence that heterogeneity might have on the mean extraction value can be minimized by using an appropriate calculation of the extraction of the test substance.
AB - Blood-brain barrier permeability studies made in man using the indicator dilution method revealed that the extraction of the test substance increases during the upslope of the venous (outflow) dilution curve. The present study aimed to obviate the possibility that this could result from intravascular phenomena, such as interlaminar diffusion (the result of differences in molecular size) and erythrocyte carriage. Several reference substances were employed for the determination of the extraction in order that careful correction could be made for differences in intravascular behavior of the test and reference substance. The test substances studied were D-glucose, L-phenylalanine, water, propranolol, and benzodiazepines, representing both carrier-transported and lipophilic substances. In-diethylenetriamine pentaacetic acid, Na+, Cl-, L-glucose, and L-lysine were employed as reference substances. For all the substances tested, and after correction for intravascular phenomena, the extractions were found to increase during the initial part of the dilution curve. This increasing extraction can be ascribed to heterogeneity of the cerebral circulation; the higher extraction corresponds to longer contact with the blood-brain barrier and indicates a longer transit time. Signs of heterogeneity were also present when blood flow was elevated above normal. Any influence that heterogeneity might have on the mean extraction value can be minimized by using an appropriate calculation of the extraction of the test substance.
KW - Blood Glucose/metabolism
KW - Blood-Brain Barrier
KW - Capillaries
KW - Cerebrovascular Circulation
KW - Clonazepam/blood
KW - Diazepam/blood
KW - Erythrocytes/metabolism
KW - Humans
KW - Indicator Dilution Techniques
KW - Nitrazepam/blood
KW - Permeability
KW - Phenylalanine/blood
KW - Propranolol/blood
KW - Water/metabolism
U2 - 10.1172/JCI109769
DO - 10.1172/JCI109769
M3 - Journal article
C2 - 6988458
VL - 65
SP - 1145
EP - 1151
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
SN - 0021-9738
IS - 5
ER -
ID: 279596347